SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Trading Statement

9 Oct 2014 07:00

RNS Number : 8130T
Victrex PLC
09 October 2014
 



 

 

 

 

9 October 2014

 

Victrex plc - Pre-close trading statement

 

"A strong finish to 2014 - growth momentum continues"

 

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its pre-close trading statement for the financial year ended 30 September 2014, ahead of its preliminary results on Tuesday 9 December 2014.

 

Victrex delivered a strong finish to 2014, with the Group continuing its volume growth momentum from the first half year across our strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Full year Group sales volume of 3,551 tonnes increased by 22% (2013: 2,920 tonnes), with second half year sales volume of 1,967 tonnes increasing by 29% on last year (H2 2013: 1,528 tonnes). Although sales volumes were particularly strong, our profit expectations remain largely unchanged.

 

The strong volume performance in our Victrex Polymer Solutions (VPS) business reflects core growth and higher than expected volumes in the second half year from Consumer Electronics. Stripping out sales volumes across the entire Electronics segment, second half year sales volume increased by 6% on the prior year. Our higher margin Speciality Products business, including Aptiv film, again performed well during the year. With continued growth in Aptiv, we will bring an additional production line on stream during the first half of our new financial year.

 

In our higher margin Invibio medical business, full year revenue increased by 5% to £53.4m (2013: £50.8m), reflecting steady improvement in the Spine market. The focus for 2015 remains the roll-out of new products into the Spine market, with regulatory applications lodged in the US and Europe for the innovative PEEK-OPTIMA® HA-Enhanced product, which enhances bone-on-growth. Pending regulatory approval, adoption and roll-out will commence during the first half.

 

As we start our new financial year, our growth momentum remains positive. Although currency headwinds remain considerable in 2015, our forthcoming new PEEK and Aptiv film capacity, technical excellence and marketing know-how keep us well placed to continue driving growth and creating value, in line with our long term strategy.

 

Enquiries:

 

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 1253 898121

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

 

Pendomer Communications:

Charles Armitstead / Rebecca Hall +44 (0) 203 603 5220

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions focused on the strategic markets of Aerospace, Automotive, Electronics, Energy and Medical. Every day, millions of people rely on products or applications which contain our polymers, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are investing in technical excellence to deliver new and leading edge solutions to our customers and our markets, and to drive value for our shareholders. Visit www.victrexplc.com

 

Investor and analyst call:

A call for investors and analysts will be held today, Thursday 9 October 08.30 UK time. For dial in details contact Rebecca Hall at Pendomer on +44 (0) 203 603 5220 or Rebecca.Hall@pendomer.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGGBAUUPCGCR
Date   Source Headline
27th Feb 201510:00 amRNSTotal Voting Rights
26th Feb 20154:53 pmRNSHolding(s) in Company
25th Feb 20154:43 pmRNSHolding(s) in Company
19th Feb 20153:03 pmRNSDirector/PDMR Shareholding
17th Feb 20152:25 pmRNSDirector/PDMR Shareholding
4th Feb 20153:59 pmRNSResult of AGM
4th Feb 20157:00 amRNSAGM and Q1 Interim Management Statement
30th Jan 20152:00 pmRNSTotal Voting Rights
26th Jan 201512:03 pmRNSDirector Declaration
19th Jan 20153:38 pmRNSDirector/PDMR Shareholding
14th Jan 20154:00 pmRNSHolding(s) in Company
5th Jan 201511:43 amRNSAnnual Financial Report
31st Dec 20147:00 amRNSTotal Voting Rights
19th Dec 20147:00 amRNSDirector Declaration
18th Dec 20148:34 amRNSDirectorate Change
18th Dec 20147:00 amRNSDirectorate Change
17th Dec 201412:45 pmRNSDirector/PDMR Shareholding
16th Dec 20145:13 pmRNSDirector/PDMR Shareholding
16th Dec 20144:43 pmRNSDirector/PDMR Shareholding
9th Dec 20147:00 amRNSFinal Results
1st Dec 20141:51 pmRNSBlocklisting Interim Review
28th Nov 201410:00 amRNSTotal Voting Rights
25th Nov 20144:30 pmRNSHolding(s) in Company
18th Nov 201411:38 amRNSDirector/PDMR Shareholding
6th Nov 201411:12 amRNSDirector Declaration
31st Oct 20149:27 amRNSTotal Voting Rights
21st Oct 20143:14 pmRNSSenior Independent Director Appointment
20th Oct 20144:38 pmRNSHolding(s) in Company
20th Oct 20149:05 amRNSDirector/PDMR Shareholding
9th Oct 20147:00 amRNSTrading Statement
1st Oct 20143:56 pmRNSDirector Disclosure Section 430 (2B)
1st Oct 20147:00 amRNSDirectorate Change
30th Sep 20141:34 pmRNSTotal Voting Rights
24th Sep 20144:12 pmRNSHolding(s) in Company
17th Sep 20141:16 pmRNSDirector/PDMR Shareholding
29th Aug 201410:00 amRNSTotal Voting Rights
19th Aug 20142:34 pmRNSDirector/PDMR Shareholding
31st Jul 20149:37 amRNSTotal Voting Rights
30th Jul 20147:00 amRNSInterim Management Statement
21st Jul 20142:13 pmRNSHolding(s) in Company
30th Jun 20142:54 pmRNSTotal Voting Rights
27th Jun 20144:00 pmRNSHolding(s) in Company
23rd Jun 201411:07 amRNSHolding(s) in Company
17th Jun 20144:04 pmRNSDirector/PDMR Shareholding
9th Jun 201411:18 amRNSBlocklisting Interim Review
4th Jun 20142:28 pmRNSDirector/PDMR Shareholding
30th May 201412:00 pmRNSTotal Voting Rights
27th May 20143:09 pmRNSDirector/PDMR Shareholding
20th May 20147:06 amRNSDirectorate Change
20th May 20147:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.